These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27650493)
1. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients. Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493 [TBL] [Abstract][Full Text] [Related]
2. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers. Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620 [TBL] [Abstract][Full Text] [Related]
3. [Expressions of CXCL8, CXCL10 and Th1 /Th2 cytokines in the serum and cerebrospinal fluid of patients with neurosyphilis]. Yu XY; Yan N; Li ZH; Chen W; Hua YH; Lu Y Zhonghua Nan Ke Xue; 2020 Apr; 26(4):335-340. PubMed ID: 33351301 [TBL] [Abstract][Full Text] [Related]
4. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis. Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE). Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis. Li D; Huang X; Shi M; Luo L; Tao C Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504 [TBL] [Abstract][Full Text] [Related]
7. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients. Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888 [TBL] [Abstract][Full Text] [Related]
8. CXCL13, CXCL10 and CXCL8 as Indicators of Ocular and Neurological Involvement in Patients With Ocular Syphilis: An Observational Descriptive Study. van der Merwe LW; Snyders C; Kidd M; Chegou NN; Walzl G; Smit DP Front Ophthalmol (Lausanne); 2022; 2():916718. PubMed ID: 38983560 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis. Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846 [TBL] [Abstract][Full Text] [Related]
10. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380 [TBL] [Abstract][Full Text] [Related]
11. Has CXCL13 an added value in diagnosis of neurosyphilis? Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544 [TBL] [Abstract][Full Text] [Related]
12. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients. Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995 [TBL] [Abstract][Full Text] [Related]
13. Increased CCL24 and CXCL7 levels in the cerebrospinal fluid of patients with neurosyphilis. Li XX; Zhang J; Wang ZY; Chen SQ; Zhou WF; Wang TT; Man XY; Zheng M J Clin Lab Anal; 2020 Sep; 34(9):e23366. PubMed ID: 32419252 [TBL] [Abstract][Full Text] [Related]
14. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance. Gudowska-Sawczuk M; Mroczko B Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis. Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573 [TBL] [Abstract][Full Text] [Related]
16. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid. Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218 [TBL] [Abstract][Full Text] [Related]
17. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis. Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424 [TBL] [Abstract][Full Text] [Related]
18. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study. Han BK; Kuzin I; Gaughan JP; Olsen NJ; Bottaro A Arthritis Res Ther; 2016 Apr; 18():93. PubMed ID: 27102921 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV. Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581 [TBL] [Abstract][Full Text] [Related]
20. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis. Marra CM Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]